Literature DB >> 20826087

Radiosensitization of cancer cells by hydroxychalcones.

Rory Pruitt1, Nidhish Sasi, Michael L Freeman, Konjeti R Sekhar.   

Abstract

Radiation sensitization is significantly increased by proteotoxic stress, such as a heat shock. We undertook an investigation, seeking to identify natural products that induced proteotoxic stress and then determined if a compound exhibited radiosensitizing properties. The hydroxychalcones, 2',5'-dihydroxychalcone (D-601) and 2,2'-dihydroxychalcone (D-501), were found to activate heat shock factor 1 (Hsf1) and exhibited radiation sensitization properties in colon and pancreatic cancer cells. The radiosensitization ability of D-601 was blocked by pretreatment with α-napthoflavone (ANF), a specific inhibitor of cytochrome P450 1A2 (CYP1A2), suggesting that the metabolite of D-601 is essential for radiosensitization. The study demonstrated the ability of hydroxychalcones to radiosensitize cancer cells and provides new leads for developing novel radiation sensitizers.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20826087      PMCID: PMC2946792          DOI: 10.1016/j.bmcl.2010.08.081

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  28 in total

1.  Alterations in heat-induced radiosensitization accompanied by nuclear structure alterations in Chinese hamster cells.

Authors:  Andrei Laszlo; Teri Davidson; Amanda Harvey; Julia E Sim; Robert S Malyapa; Douglas R Spitz; Joseph L Roti Roti
Journal:  Int J Hyperthermia       Date:  2006-02       Impact factor: 3.914

2.  Thermochemotherapy in patients with extremity high-risk soft tissue sarcomas (HR-STS).

Authors:  M Schlemmer; C M Wendtner; L Lindner; S Abdel-Rahman; W Hiddemann; R D Issels
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

3.  Novel substituted (Z)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-one and (Z)-(+/-)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-ol derivatives as potent thermal sensitizing agents.

Authors:  Vijayakumar N Sonar; Y Thirupathi Reddy; Konjeti R Sekhar; Soumya Sasi; Michael L Freeman; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2007-10-17       Impact factor: 2.823

4.  Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer.

Authors:  Tse-Kuan Yu; Priya R Bhosale; Christopher H Crane; Revathy B Iyer; John M Skibber; Miguel A Rodriguez-Bigas; Barry W Feig; George J Chang; Cathy Eng; Robert A Wolff; Nora A Janjan; Marc E Delclos; Sunil Krishnan; Prajnan Das
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-01-22       Impact factor: 7.038

5.  In vitro metabolism of isoliquiritigenin by human liver microsomes.

Authors:  Jian Guo; Dongting Liu; Dejan Nikolic; Dongwei Zhu; John M Pezzuto; Richard B van Breemen
Journal:  Drug Metab Dispos       Date:  2007-11-15       Impact factor: 3.922

6.  Two-step mechanism of induction of the gene expression of a prototypic cancer-protective enzyme by diphenols.

Authors:  René V Bensasson; Vincent Zoete; Albena T Dinkova-Kostova; Paul Talalay
Journal:  Chem Res Toxicol       Date:  2008-03-25       Impact factor: 3.739

7.  The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.

Authors:  Koen C M J Peeters; Corrie A M Marijnen; Iris D Nagtegaal; Elma Klein Kranenbarg; Hein Putter; Theo Wiggers; Harm Rutten; Lars Pahlman; Bengt Glimelius; Jan Willem Leer; Cornelis J H van de Velde
Journal:  Ann Surg       Date:  2007-11       Impact factor: 12.969

8.  Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: the CORGI-L Study.

Authors:  Adalsteinn Gunnlaugsson; Harald Anderson; Eva Fernebro; Elisabeth Kjellén; Per Byström; Ke Berglund; Mats Ekelund; Lars Påhlman; Torbjörn Holm; Bengt Glimelius; Anders Johnsson
Journal:  Eur J Cancer       Date:  2008-12-26       Impact factor: 9.162

9.  Biotransformation of the chemopreventive agent 2',4',4-trihydroxychalcone (isoliquiritigenin) by UDP-glucuronosyltransferases.

Authors:  Jian Guo; Ang Liu; Hongmei Cao; Yan Luo; John M Pezzuto; Richard B van Breemen
Journal:  Drug Metab Dispos       Date:  2008-07-24       Impact factor: 3.922

10.  Protein denaturation in intact hepatocytes and isolated cellular organelles during heat shock.

Authors:  J R Lepock; H E Frey; K P Ritchie
Journal:  J Cell Biol       Date:  1993-09       Impact factor: 10.539

View more
  2 in total

Review 1.  Biological determinants of radioresistance and their remediation in pancreatic cancer.

Authors:  Parthasarathy Seshacharyulu; Michael J Baine; Joshua J Souchek; Melanie Menning; Sukhwinder Kaur; Ying Yan; Michel M Ouellette; Maneesh Jain; Chi Lin; Surinder K Batra
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-02-27       Impact factor: 10.680

Review 2.  Potential Contributions of Antioxidants to Cancer Therapy: Immunomodulation and Radiosensitization.

Authors:  Anita Thyagarajan; Ravi P Sahu
Journal:  Integr Cancer Ther       Date:  2017-03-20       Impact factor: 3.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.